Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Mediobanca launches €6.3bn bid for Banca Generali

(Sharecast News) - Italy's Mediobanca on Monday unveiled a €6.3bn bid for rival Banca Generali in a move to expand its wealth management division. Mediobanca said it would fund the deal by selling its 13% stake in Assicurazioni Generali, which is the country's largest insurer, in an exchange offer worth €54.17 a share, an 11.4% premium to Banca Generali's last close.

The offer adds to a list of takeovers in Italy's banking sector. Mediobanca is itself subject to a hostile bid from Banca Monte dei Paschi di Siena, while UniCredit is trying to buy smaller rival Banco BPM, which in turn is trying to snare asset manager Anima Holding.

Mediobanca rejected a €13.3bn bid from MPS, which was supported by Prime Minister Giorgia Meloni's government.

Mediobanca estimated that the deal would produce around €300 million in cost synergies. It added that the acquisition would double its wealth management revenues to €2bn and that net profit would increase fourfold to €800m.

Reporting by Frank Prenesti for Sharecast.com

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.